Pulmonary Embolism and COVID-19

NCT04590378 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2021-05-04

No results posted yet for this study

Summary

The charts of patients who developed pulmonary embolism in the course of COVID-19 will be evaluated, retrospectively. Clinical features and laboratory data will be analyzed.

Conditions

Interventions

OTHER

intensive care unit admission ratio

intensive care unit admission ratio

Sponsors & Collaborators

  • Uşak University

    lead OTHER

Principal Investigators

  • Cevdet Duran, M.D. · Uşak University Medical School

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-06-01
Completion
2021-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590378 on ClinicalTrials.gov